Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...

RBC Capital raised the firm’s price target on Exelixis (EXEL) to $38 from $34 and keeps an Outperform rating on the shares. Zanzalintinib ...

Zanzalintinib stands out as Exelixis’ most clinically advanced asset with potential to become a primary contributor in the medium to long term, says the analyst, who is incorporating zanza into ...

The company’s major pipeline product candidates include zanzalintinib, XB002 and XL102 for the treatment of advanced or metastatic solid tumors, and CBX-12 for advanced metastatic refractory solid ...

Chevron (CVX) reachead $143.07 at the closing of the latest trading day, reflecting a -0.65% change compared to its last close.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

A Brazilian influencer whose staggering 32-stone weight loss made him the star of a reality TV show has died aged 37 after piling on the pounds again following the loss of his dad and brother ...

He will be sentenced on Jan. 10, shortly before his inauguration, but is unlikely to face jail time or other penalties. United Statescategory Even before US alcohol warning, younger Americans were ...

Christian converts in Kosovo, where the vast majority of people are Muslim, hope to revive a pre-Islamic past they see as a key to their European identity. By Andrew Higgins and Fatjona Mejdini ...